[1]
M. A. E. A. Elgasim, “Benefits of Docetaxel for Metastatic Castration-Resistant Prostate Cancer Sudanese Patients and the Effective Number of Cycle and Dose (2013–2017)”, IRJO, vol. 2, no. 2, pp. 1-9, Jul. 2019.